A photo of Peter de Blank.

Member, Division of Oncology

Associate Professor, UC Department of Pediatrics


Board Certified

Best Doctors logo

My Biography & Research


Dr. de Blank graduated from the University of California, San Francisco School of Medicine with a concentration in Medical Education. He completed his residency in Pediatrics, and fellowships in Pediatric Hematology & Oncology and Pediatric Neuro-Oncology at the Children’s Hospital of Philadelphia. He completed a Masters of Science in Clinical Epidemiology and Biostatistics at the University of Pennsylvania during his fellowship training. After completing his training, he became a faculty member at University Hospitals Rainbow Babies & Children’s Hospital in Cleveland in 2012. In 2017, Dr. de Blank joined the faculty at Cincinnati Children’s Hospital Medical Center as a member of the Pediatric Neuro-Oncology program.

Dr. de Blank’s clinical and research interests include children with central nervous system tumors, neurofibromatosis type 1 (NF1), and NF1-related tumors. His research focuses on the investigation of tissue microstructure in pediatric brain tumors through non-invasive imaging techniques such as MR relaxometry and diffusion tensor imaging. The goal of his research is to develop early radiographic tumor biomarkers to characterize pediatric brain tumors and predict their functional consequences. Tumor imaging research may guide early intervention efforts and direct support for children with brain tumors in order to improve clinical outcomes in children with brain tumors.

Dr. de Blank has been elected by peers for inclusion in the Best Doctors in America List.

Clinical Interests

Pediatric neuro-oncology; neurofibromatosis type 1 (NF1); NF1-associated brain tumors

Research Interests

Cancer imaging; diffusion tensor imaging; MR relaxometry; magnetic resonance fingerprinting; developmental therapeutics

Academic Affiliation

Associate Professor, UC Department of Pediatrics


Cancer and Blood Diseases, Brain Tumor, Rasopathy, Neurofibromatosis, Cancer and Blood Diseases, Oncology

My Locations

My Education

BA: Stanford University, Stanford, CA, 1997.

BS: Chemistry, Stanford University, Stanford, CA, 1997.

MA: Stanford University, Stanford, CA, 1997.

MD: Emphasis in Medical Education, University of California, San Francisco School of Medicine, San Francisco, CA, 2005.

MS: Clinical Epidemiology, University of Pennsylvania, Center for Clinical Epidemiology and Biostatistics, Philadelphia, PA, 2011.

Intern: Pediatrics, The Children’s Hospital of Philadelphia, Philadelphia, PA, 2005-2006.

Resident: Pediatrics, The Children’s Hospital of Philadelphia, Philadelphia, PA, 2006-2008.

Fellow: Pediatric Hematology and Oncology, The Children’s Hospital of Philadelphia, Philadelphia, PA, 2008-2011; Pediatric Neuro-Oncology, The Children’s Hospital of Philadelphia, Philadelphia, PA, 2011-2012.

My Publications

Subsequent neoplasms after a primary tumor in individuals with neurofibromatosis type 1. Bhatia, S; Chen, Y; Wong, FL; Hageman, L; Smith, K; Korf, B; Cannon, A; Leidy, DJ; Paz, A; Andress, JE; et al. Journal of Clinical Oncology. 2019; 37:3050-3058.

Magnetic Resonance Fingerprinting to Characterize Childhood and Young Adult Brain Tumors. de Blank, P; Badve, C; Gold, DR; Stearns, D; Sunshine, J; Dastmalchian, S; Tomei, K; Sloan, AE; Barnholtz-Sloan, JS; Lane, A; et al. Pediatric Neurosurgery. 2019; 54:310-318.

Management of pediatric low-grade glioma. de Blank, P; Bandopadhayay, P; Haas-Kogan, D; Fouladi, M; Fangusaro, J. Current Opinion in Pediatrics. 2019; 31:21-27.

Neuro-Oncologic Considerations in Pediatric Oculoplastic Surgery. de Blank, PM; Coffey, M; Fisher, MJ. In: Katowitz JA; Katowitz WR, Ed. Pediatric Oculoplastic Surgery. Cham, Switzerland: Springer; 2018.

2016 Children's Tumor Foundation conference on neurofibromatosis type 1, neurofibromatosis type 2, and schwannomatosis. Fisher, MJ; Belzberg, AJ; de Blank, P; De Raedt, T; Elefteriou, F; Ferner, RE; Giovannini, M; Harris, GJ; Kalamarides, M; Karajannis, MA; et al. American Journal of Medical Genetics, Part A. 2018; 176:1258-1269.

Validation of an automated tractography method for the optic radiations as a biomarker of visual acuity in neurofibromatosis-associated optic pathway glioma. de Blank, P; Fisher, MJ; Gittleman, H; Barnholtz-Sloan, JS; Badve, C; Berman, JI. Experimental Neurology. 2018; 299:308-316.

Incidence and survival trends for medulloblastomas in the United States from 2001 to 2013. Khanna, V; Achey, RL; Ostrom, QT; Block-Beach, H; Kruchko, C; Barnholtz-Sloan, JS; de Blank, PM. Journal of Neuro-Oncology. 2017; 135:433-441.

Childhood Cancer and Brain Tumor Late Effects: Relationships with Family Burden and Survivor Psychological Outcomes. Cousino, MK; Hazen, R; Josie, KL; Laschinger, K; de Blank, P; Taylor, HG. Journal of Clinical Psychology in Medical Settings. 2017; 24:279-288.

Optic Pathway Gliomas in Neurofibromatosis Type 1: An Update: Surveillance, Treatment Indications, and Biomarkers of Vision. de Blank, PM K; Fisher, MJ; Liu, GT; Gutmann, DH; Listernick, R; Ferner, RE; Avery, RA. Journal of Neuro-Ophthalmology. 2017; 37 Suppl 1:S23-S32.

Choroid plexus tumors in adult and pediatric populations: the Cleveland Clinic and University Hospitals experience. Bahar, M; Hashem, H; Tekautz, T; Worley, S; Tang, A; de Blank, P; Wolff, J. Journal of Neuro-Oncology. 2017; 132:427-432.